On December 27, 2023, Ruibo (Hangzhou) Pharmaceutical Technology Co., Ltd. closed the transaction. The company has completed the industrial and commercial change registration and obtained a new Business License issued by the Hangzhou Qiantang District Market Supervision Administration.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.6 CNY | +3.24% | +5.62% | -35.56% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.56% | 1.94B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Ruibo Pharmaceutical Technology Co., Ltd. announced that it has received CNY 50 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd